Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 116 Records) |
| Query Trace: Glioblastoma and EGFR[original query] |
|---|
| Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy. Frontiers in immunology 2021 9 12 729359. Ji Hang, Ba Yixu, Ma Shuai, Hou Kuiyuan, Mi Shan, Gao Xin, Jin Jiaqi, Gong Qin, Liu Ting, Wang Fang, Liu Zhihui, Li Shupeng, Du Jianyang, Hu Shaosh |
| Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Scientific reports 2021 Sep 11 (1): 18009. Zaki Mark M, Mashouf Leila A, Woodward Eleanor, Langat Pinky, Gupta Saksham, Dunn Ian F, Wen Patrick Y, Nahed Brian V, Bi Wenya Lin |
| Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients. Journal of translational medicine 2021 8 19 (1): 372. Zhao Hua-Fu, Zhou Xiu-Ming, Wang Jing, Chen Fan-Fan, Wu Chang-Peng, Diao Peng-Yu, Cai Lin-Rong, Chen Lei, Xu Yan-Wen, Liu Jing, Li Zong-Yang, Liu Wen-Lan, Chen Zhong-Ping, Huang Guo-Dong, Li Wei-Pi |
| The role of RB1 alteration and 4q12 amplification in IDH-WT glioblastoma. Neuro-oncology advances 2021 6 3 (1): vdab050. Dono Antonio, Ramesh Arvind V, Wang Emily, Shah Mauli, Tandon Nitin, Ballester Leomar Y, Esquenazi Yosh |
| Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis. Cancer management and research 2021 5 13 3573-3588. Zeng Chun, Wang Jing, Li Mingwei, Wang Huina, Lou Feng, Cao Shanbo, Lu Chang |
| Frequency and Prognosis of Epidermal Growth Factor Receptor Variant III Mutations in Glioblastoma Multiforme among Indian Patients: A Single-Institution Study. South Asian journal of cancer 2021 5 9 (3): 126-129. Jose Wesley Mannirathil, Munirathnam Vinayak, Narendranath V, Philip Arun, Keechilat Pavithr |
| Whole-exome sequencing, EGFR amplification and infiltration patterns in human glioblastoma. American journal of cancer research 2021 12 11 (11): 5543-5558. López-Ginés Concha, Muñoz-Hidalgo Lisandra, San-Miguel Teresa, Megías Javier, Triviño Juan Carlos, Calabuig Silvia, Roldán Pedro, Cerdá-Nicolás Miguel, Monleón Dani |
| IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation. Acta neuropathologica communications 2021 12 9 (1): 200. Barresi Valeria, Simbolo Michele, Mafficini Andrea, Martini Maurizio, Calicchia Martina, Piredda Maria Liliana, Ciaparrone Chiara, Bonizzato Giada, Ammendola Serena, Caffo Maria, Pinna Giampietro, Sala Francesco, Lawlor Rita Teresa, Ghimenton Claudio, Scarpa Al |
| Prognostic implications of epidermal and platelet-derived growth factor receptor alterations in 2 cohorts of IDHwt glioblastoma. Neuro-oncology advances 2021 10 3 (1): vdab127. Alnahhas Iyad, Rayi Appaji, Guillermo Prieto Eibl Maria Del Pilar, Ong Shirley, Giglio Pierre, Puduvalli Vin |
| Epidermal Growth Factor Receptor Variant III Mutation, an Emerging Molecular Marker in Glioblastoma Multiforme Patients: A Single Institution Study on the Indian Population. Cureus 2022 8 14 (6): e26412. Garima Garima, Thanvi Sharad, Singh Anurag, Verma Vij |
| A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. Life (Basel, Switzerland) 2022 Jun 12 (7): . Guarnaccia Maria, Guarnaccia Laura, La Cognata Valentina, Navone Stefania Elena, Campanella Rolando, Ampollini Antonella, Locatelli Marco, Miozzo Monica, Marfia Giovanni, Cavallaro Sebastia |
| Clinical, histopathological, and molecular features of IDH-wildtype indolent diffuse glioma: comparison with typical glioblastoma. Journal of neuro-oncology 2022 7 159 (2): 397-408. Suzuki Hayato, Ono Takahiro, Koyota Souichi, Takahashi Masataka, Sugai Tamotsu, Nanjo Hiroshi, Shimizu Hiroa |
| Distribution and favorable prognostic implication of genomic EGFR alterations in IDH-wildtype glioblastoma. Cancer medicine 2022 Jun . Higa Nayuta, Akahane Toshiaki, Hamada Taiji, Yonezawa Hajime, Uchida Hiroyuki, Makino Ryutaro, Watanabe Shoji, Takajo Tomoko, Yokoyama Seiya, Kirishima Mari, Matsuo Kei, Fujio Shingo, Hanaya Ryosuke, Tanimoto Akihide, Yoshimoto Ko |
| EGFR Mutations in GBM Alter Ligand Binding and Subsequent Dimerization. Cancer discovery 2022 4 12 (4): 884. Authors are not available |
| Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (12): 2527-2535. Tesileanu C Mircea S, Sanson Marc, Wick Wolfgang, Brandes Alba A, Clement Paul M, Erridge Sara C, Vogelbaum Michael A, Nowak Anna K, Baurain Jean-Francois, Mason Warren P, Wheeler Helen, Chinot Olivier L, Gill Sanjeev, Griffin Matthew, Rogers Leland, Taal Walter, Rudà Roberta, Weller Michael, McBain Catherine, van Linde Myra E, Aldape Kenneth, Jenkins Robert B, Kros Johan M, Wesseling Pieter, von Deimling Andreas, Hoogstrate Youri, de Heer Iris, Atmodimedjo Peggy N, Dubbink Hendrikus J, Brouwer Rutger W W, van IJcken Wilfred F J, Cheung Kin Jip, Golfinopoulos Vassilis, Baumert Brigitta G, Gorlia Thierry, French Pim J, van den Bent Martin |
| Mitochondrial DNA copy number as a prognostic marker is age-dependent in adult glioblastoma. Neuro-oncology advances 2022 2 4 (1): vdab191. Sourty Baptiste, Dardaud Laure-Marie, Bris Céline, Desquiret-Dumas Valérie, Boisselier Blandine, Basset Laëtitia, Figarella-Branger Dominique, Morel Alain, Sanson Marc, Procaccio Vincent, Rousseau Audr |
| The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study. Journal of neuro-oncology 2022 2 157 (1): 177-185. Ramos-Fresnedo Andres, Pullen Michael W, Perez-Vega Carlos, Domingo Ricardo A, Akinduro Oluwaseun O, Almeida Joao P, Suarez-Meade Paola, Marenco-Hillembrand Lina, Jentoft Mark E, Bendok Bernard R, Trifiletti Daniel M, Chaichana Kaisorn L, Porter Alyx B, Quiñones-Hinojosa Alfredo, Burns Terence C, Kizilbash Sani H, Middlebrooks Erik H, Sherman Wendy |
| Multivariate analysis of associations between clinical sequencing and outcome in glioblastoma. Neuro-oncology advances 2022 2 4 (1): vdac002. Yang Peter H, Tao Yu, Luo Jingqin, Paturu Mounica, Lu Hsiang-Chih, Ramkissoon Shakti, Heusel Jonathan W, Leuthardt Eric C, Chicoine Michael R, Dowling Joshua L, Dunn Gavin P, Duncavage Eric, Dahiya Sonika, Chattherjee Arindam R, Kim Albert |
| Impact of EGFR mutation on relapse pattern in glioblastoma. ESMO open 2022 12 8 (1): 100740. Noeuveglise A, Sarafan-Vasseur N, Beaussire L, Marguet F, Modzelewski R, Hanzen C, Alexandru C, Magne N, Langlois O, Di Fiore F, Clatot F, Thureau S, Fontanilles |
| Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26. Neuro-oncology 2022 12 . Alpen Karen, Vajdic Claire M, MacInnis Robert J, Milne Roger L, Koh Eng-Siew, Hovey Elizabeth, Harrup Rosemary, Bruinsma Fiona, Nguyen Tuong L, Li Shuai, Joseph David, Benke Geza, Dugué Pierre-Antoine, Southey Melissa C, Giles Graham G, Rosenthal Mark, Drummond Katharine J, Nowak Anna K, Hopper John L, Kapuscinski Miroslaw, Makalic En |
| Epidemiological characteristics and genetic alterations in adult diffuse glioma in East Asian populations. Cancer biology & medicine 2022 11 19 (10): 1440-59. Mo Zongchao, Xin Junyi, Chai Ruichao, Woo Peter Y M, Chan Danny T M, Wang Jigua |
| Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study. Thrombosis research 2022 11 221 10-18. Kapteijn Maaike Y, Kaptein Fleur H J, Stals Milou A M, Klaase Eva E, García-Ortiz Inés, van Eijk Ronald, Ruano Dina, van Duinen Sjoerd G, Cannegieter Suzanne C, Taphoorn Martin J B, Dirven Linda, Koekkoek Johan A F, Klok Frederikus A, Versteeg Henri H, Buijs Jeroen |
| Impacts of genotypic variants on survival following reoperation for recurrent glioblastoma. Journal of neuro-oncology 2022 1 156 (2): 353-363. Dono Antonio, Zhu Ping, Holmes Emma, Takayasu Takeshi, Zhu Jay-Jiguang, Blanco Angel I, Hsu Sigmund, Bhattacharjee Meenakshi B, Ballester Leomar Y, Kim Dong H, Esquenazi Yoshua, Tandon Nit |
| Landscape of Genomic Alterations in IDH Wild-Type Glioblastoma Identifies PI3K as a Favorable Prognostic Factor. JCO precision oncology 2022 1 4 575-584. Yan Yuanqing, Takayasu Takeshi, Hines Gabriella, Dono Antonio, Hsu Sigmund H, Zhu Jay-Jiguang, Riascos-Castaneda Roy F, Kamali Arash, Bhattacharjee Meenakshi B, Blanco Angel I, Tandon Nitin, Kim Dong H, Ballester Leomar Y, Esquenazi And Yosh |
| Alterations in EGFR and PDGFRA are associated with the localization of contrast-enhancing lesions in glioblastoma. Neuro-oncology advances 2023 9 5 (1): vdad110. Ryutaro Makino, Nayuta Higa, Toshiaki Akahane, Hajime Yonezawa, Hiroyuki Uchida, Tomoko Takajo, Shingo Fujio, Mari Kirishima, Taiji Hamada, Hitoshi Yamahata, Kiyohisa Kamimura, Takashi Yoshiura, Koji Yoshimoto, Akihide Tanimoto, Ryosuke Hana |
| A case of glioblastoma harboring non-amplified epidermal growth factor receptor variant III: Critical molecular detection using RNA-based panel analysis. Pathology, research and practice 2023 7 248 154712. Mari Kirishima, Toshiaki Akahane, Tomoko Takajo, Nayuta Higa, Hajime Yonezawa, Hiroyuki Uchida, Kiyohisa Kamimura, Ryosuke Hanaya, Koji Yoshimoto, Michiyo Higashi, Takashi Yoshiura, Akihide Tanimo |
| EGFR-Driven Mutation in Non-Small-Cell Lung Cancer (NSCLC) Influences the Features and Outcome of Brain Metastases. Journal of clinical medicine 2023 5 12 (10): . Daniele Armocida, Alessandro Pesce, Mauro Palmieri, Fabio Cofano, Giuseppe Palmieri, Paola Cassoni, Carla Letizia Busceti, Francesca Biagioni, Diego Garbossa, Francesco Fornai, Antonio Santoro, Alessandro Fra |
| Identification of INSRR as an immune-related gene in the tumor microenvironment of glioblastoma by integrated bioinformatics analysis. Medical oncology (Northwood, London, England) 2023 4 40 (6): 161. Haofuzi Zhang, Mingdong Bao, Dan Liao, Zhuoyuan Zhang, Zhicheng Tian, Erwan Yang, Peng Luo, Xiaofan Jia |
| Almonertinib Combined with Anlotinib and Temozolomide in a Patient with Recurrent Glioblastoma with EGFR L858R Mutation. The oncologist 2023 3 . Hou Zhiwei, Wu Huaguo, Luo Ningning, Li Shuo, Zhang Xiang, Dong Shuai, Zhu Dongyuan, Zhang Hui, Tao Rongj |
| Stromal protein CCN family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism. Frontiers in molecular biosciences 2023 1 9 1027236. Liu Zhihui, Wu Jiasheng, Ji Hang, Zhao Hongtao, Wang Fang, Dong Jiawei, Zhang Jiheng, Wang Nan, Yan Xiuwei, Wang Kaikai, Hu Shaosh |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: